Developer docs
API playgroundTry for free, no card

Search company profiles

Algatechnologies

Full company profile

uuid000bjdf

Namestring
Algatechnologies
Websiteurl
algatech.com
Company typeenum
Private
Founded yearint
1998
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEilot, Israel
HQ citystring
Eilot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
microalgae cultivation, natural astaxanthin production, algae-based nutraceutical ingredients, algae oil omega-3, plant-based antioxidant ingredients
Industry2 codes
1AFAEAAAE
CodeAFAEAAAEPrimaryYes
2EUAAAIAE
CodeEUAAAIAEPrimaryNo
NAICS code1 code
  • 31122
SIC code2 codes
  • 2833
  • 2860
Product category
Microalgae-based Nutraceutical Ingredients
Social media profiles2 records
Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Algatechnologies is a biotechnology company that commercially cultivates microalgae to produce natural astaxanthin and algae-based ingredients, including omega-3-rich algae oil. Its products are sold to manufacturers of nutraceuticals, dietary supplements, food and beverage products, animal feed/aquaculture, and cosmetics/personal care applications.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Natural Astaxanthin
CategoryNutraceutical Ingredients
Description

Natural astaxanthin extracted from cultivated microalgae, used as a natural antioxidant and pigment ingredient for nutraceutical, food and beverage, aquaculture feed, cosmetics, and pharmaceutical manufacturers.

2Algae Oil (Omega-3)
CategoryNutraceutical Ingredients
Description

Microalgae-derived oil providing plant-based omega-3 fatty acids (EPA/DHA) for nutraceutical, dietary supplement, and functional food manufacturers seeking a sustainable alternative to fish oil.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cyanotech is a publicly-traded microalgae cultivation company producing BioAstin natural astaxanthin and Spirulina from Haematococcus pluvialis and spirulina biomass, directly comparable to Algatech's natural astaxanthin and algae-based ingredient portfolio. Both companies compete head-to-head in the same microalgae-derived nutraceutical ingredient market.

2Polaris (Microphyt)
TypeDirect peer
Description

Polaris/Microphyt is a French microalgae biotechnology company focused on cultivation and extraction of microalgae ingredients including omega-3s, carotenoids, and specialty extracts. They are explicitly named alongside Algatech as a major competitor in the microalgae oil supplement market, sharing the same cultivation-led production model.

3Qualitas Health (iQ Health)
TypeDirect peer
Description

Qualitas Health is an Israel-based microalgae company producing algae oil for omega-3 supplementation and aquaculture feed. As an Israeli peer (Algatech is also Israeli) named in competitor analysis, they share target molecules, customer segments, and cultivation-first positioning.

TypeBroad incumbent
Description

DSM operates as a global specialty ingredients powerhouse, including its Life's DHA algal omega-3 platform. While much broader than Algatech, DSM is explicitly identified as a major competitor in microalgae oil supplements and competes across the same omega-3 and natural antioxidant categories.

TypeBroad incumbent
Description

Corbion operates AlgaPrime, an algae-based DHA feed ingredient business alongside its broader portfolio of food ingredients and biochemicals (including lactic acid). Named alongside Algatech as a major microalgae oil competitor, they overlap in serving aquaculture and nutraceutical formulations.

TypeBroad incumbent
Description

Earthrise is one of the world's largest spirulina producers, now part of Japanese specialty chemicals group DIC. They share with Algatech the cultivation-based production model and overlap in serving natural colorants and antioxidant end-uses via microalgae biomass.

TypeDirect peer
Description

Parry Nutraceuticals is an India-headquartered microalgae cultivation company producing spirulina, chlorella, and algal DHA for supplements, food, and aquaculture. They share the same cultivation-driven ingredient business model and target end-markets as Algatech.

TypeEmerging player
Description

Heliae is a US-based microalgae technology company focused on specialty algae-based products for human nutrition, animal nutrition, and agriculture. While smaller and more venture-backed than Algatech, they compete in adjacent microalgae cultivation and ingredient spaces with overlapping customer targets.

TypeBroad incumbent
Description

Kemin is a privately held specialty ingredient manufacturer producing natural carotenoids (including astaxanthin) and functional ingredients for human and animal nutrition. They overlap with Algatech's antioxidant and astaxanthin offerings while serving similar nutraceutical and feed customers.

10AlgaTechno
TypeEmerging player
Description

AlgaTechno is an emerging microalgae ingredient supplier producing astaxanthin and omega-3 algae oil from Haematococcus pluvialis. Despite different corporate heritage, they target many of the same ingredient customers as Algatech from a similar cultivation-first production model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Algatechnologies

Microalgae-based Nutraceutical Ingredientsalgatech.com

Algatechnologies firmographics

Firmographics
Name
Algatechnologies
Website
https://algatech.com
Company type
Private
Founded year
1998
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Algatechnologies is headquartered

Location

Headquarters

HQ city
Eilot
HQ country
Israel
HQ region
Middle East

Markets served

Algatechnologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Algatechnologies product offering

Product offering

Core offering

Algatechnologies is a biotechnology company that commercially cultivates microalgae to produce natural astaxanthin and algae-based ingredients, including omega-3-rich algae oil. Its products are sold to manufacturers of nutraceuticals, dietary supplements, food and beverage products, animal feed/aquaculture, and cosmetics/personal care applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Natural Astaxanthin Natural astaxanthin extracted from cultivated microalgae, used as a natural antioxidant and pigment ingredient for nutraceutical, food and beverage, aquaculture feed, cosmetics, and pharmaceutical manufacturers.
  • Algae Oil (Omega-3) Microalgae-derived oil providing plant-based omega-3 fatty acids (EPA/DHA) for nutraceutical, dietary supplement, and functional food manufacturers seeking a sustainable alternative to fish oil.

Companies that use Algatechnologies

Customer profile

Segments4 records

Ideal customer profiles4 records

Algatechnologies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Algatechnologies partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves3 records

Expansion highlights3 records

Algatechnologies competitors and assessment

Company assessment

Direct peers

  • Cyanotech Corporation: Cyanotech is a publicly-traded microalgae cultivation company producing BioAstin natural astaxanthin and Spirulina from Haematococcus pluvialis and spirulina biomass, directly comparable to Algatech's natural astaxanthin and algae-based ingredient portfolio. Both companies compete head-to-head in the same microalgae-derived nutraceutical ingredient market.
  • Polaris (Microphyt): Polaris/Microphyt is a French microalgae biotechnology company focused on cultivation and extraction of microalgae ingredients including omega-3s, carotenoids, and specialty extracts. They are explicitly named alongside Algatech as a major competitor in the microalgae oil supplement market, sharing the same cultivation-led production model.
  • Qualitas Health (iQ Health): Qualitas Health is an Israel-based microalgae company producing algae oil for omega-3 supplementation and aquaculture feed. As an Israeli peer (Algatech is also Israeli) named in competitor analysis, they share target molecules, customer segments, and cultivation-first positioning.
  • Parry Nutraceuticals (Murugappa Group): Parry Nutraceuticals is an India-headquartered microalgae cultivation company producing spirulina, chlorella, and algal DHA for supplements, food, and aquaculture. They share the same cultivation-driven ingredient business model and target end-markets as Algatech.

Broad incumbents

  • dsm-firmenich (DSM): DSM operates as a global specialty ingredients powerhouse, including its Life's DHA algal omega-3 platform. While much broader than Algatech, DSM is explicitly identified as a major competitor in microalgae oil supplements and competes across the same omega-3 and natural antioxidant categories.
  • Corbion: Corbion operates AlgaPrime, an algae-based DHA feed ingredient business alongside its broader portfolio of food ingredients and biochemicals (including lactic acid). Named alongside Algatech as a major microalgae oil competitor, they overlap in serving aquaculture and nutraceutical formulations.
  • Earthrise Nutritionals (DIC Corporation): Earthrise is one of the world's largest spirulina producers, now part of Japanese specialty chemicals group DIC. They share with Algatech the cultivation-based production model and overlap in serving natural colorants and antioxidant end-uses via microalgae biomass.
  • Kemin Industries: Kemin is a privately held specialty ingredient manufacturer producing natural carotenoids (including astaxanthin) and functional ingredients for human and animal nutrition. They overlap with Algatech's antioxidant and astaxanthin offerings while serving similar nutraceutical and feed customers.

Emerging players

  • Heliae Development: Heliae is a US-based microalgae technology company focused on specialty algae-based products for human nutrition, animal nutrition, and agriculture. While smaller and more venture-backed than Algatech, they compete in adjacent microalgae cultivation and ingredient spaces with overlapping customer targets.
  • AlgaTechno: AlgaTechno is an emerging microalgae ingredient supplier producing astaxanthin and omega-3 algae oil from Haematococcus pluvialis. Despite different corporate heritage, they target many of the same ingredient customers as Algatech from a similar cultivation-first production model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights7 records

Customer concentration

Algatechnologies social profiles

Digital presence

Algatechnologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Algatechnologies leadership team

Management profile

Number of profiles

Profiles2 records

Algatechnologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Algatechnologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Algatechnologies

What does Algatechnologies do?

Algatechnologies is a biotechnology company that commercially cultivates microalgae to produce natural astaxanthin and algae-based ingredients, including omega-3-rich algae oil. Its products are sold to manufacturers of nutraceuticals, dietary supplements, food and beverage products, animal feed/aquaculture, and cosmetics/personal care applications.

Is Algatechnologies a public or private company?

Algatechnologies is a private company. It is classified as unknown.

When was Algatechnologies founded?

Algatechnologies was founded in 1998. It employs 11 to 50 people.

Where is Algatechnologies based?

Algatechnologies is headquartered in Eilot, Israel, in the Middle East region.

Who are Algatechnologies's main competitors?

Direct peers on record are Cyanotech Corporation, Polaris (Microphyt), Qualitas Health (iQ Health) and Parry Nutraceuticals (Murugappa Group). Broad incumbents are dsm-firmenich (DSM), Corbion, Earthrise Nutritionals (DIC Corporation) and Kemin Industries. Emerging players are Heliae Development and AlgaTechno.

Does Algatechnologies have an API?

No public API is recorded for Algatechnologies.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageTop Natural Astaxanthin Supplier for Global Buyers 2026?The article outlines the growing global demand for natural astaxanthin, projecting market values between $1.2 billion and $1.5 billion by 2026 with significant compound annual growth rates. It identifies key industry players such as AstaReal and Algatech while emphasizing the importance of quality certifications like GMP and ISO standards amidst rising concerns over product purity. The text also highlights sustainability practices and supply chain transparency as critical factors for suppliers to maintain trust with buyers in the supplement and cosmetic sectors.IftThe Sustainable, Nutritious, Functional Power of AlgaeThe global algae products market, valued at $4.7 billion, is projected to reach $6.4 billion by 2026, driven by the functional, nutritional, and sustainability benefits of algae as a food ingredient. The article explores how companies including AstaReal, Kemin, Algatech, Algaia, and GNT USA are developing algae-based products such as astaxanthin, beta-glucan, and natural blue colorings for use in foods, beverages, and supplements. Research institutions like the Technion – Israel Institute of Technology are also investigating future applications including seaweed-based seafood alternatives and new algae bioactives for the food, personal care, and agricultural industries.PR NewswireAstaPure®-EyeQ - Natural Astaxanthin Inspired by the Eagle VisionAlgatechnologies, Ltd. announced AstaPure®-EyeQ, a clinically supported microencapsulated natural astaxanthin powder developed in partnership with Italian startup Sphera Encapsulation, designed for vision and brain health applications. Clinical studies show the product delivers a two-fold increase in bioavailability compared to standard astaxanthin supplements and successfully crosses the blood-brain and blood-retina barriers. The company will launch the product at Vitafoods Europe in Geneva (May 7-9) and has partnered with UK-based EuroCaps to produce a chewable softgel format.PR NewswireFor The Biome And Algatech Forge Cutting-Edge PartnershipFor The Biome, a wellness company founded by Paul Schulick (former founder of New Chapter), has announced a partnership with Israeli microalgae innovator Algatech, securing 'first to launch' rights for new topical products. Algatech, based in Israel's Arava desert and founded in 1998, is known for AstaPure Astaxanthin, a premium natural antioxidant derived from the microalgae Haematococcus pluvialis. The collaboration aims to bring microalgae-based innovations to the beauty and natural skincare market, with Hagai Stadler, CEO of Algatech, emphasizing the partnership's goal to deliver new solutions for skin health.PR NewswireAlgatech Delivers Potent Astaxanthin in Whole-food FormatIsraeli biotechnology company Algatechnologies Ltd. launched AstaPure Arava, a clean-label whole-algae powder derived from Haematococcus Pluvialis microalgae, at Kibbutz Ketura on February 11, 2019. A study conducted by NIS Labs, a US immunity research institute, found the product exhibits highly potent and synergistic effects across multiple parameters, including positive immune responses and reparative functions at the cellular mitochondria level. The company plans to introduce new products and delivery forms based on the AstaPure Arava powder throughout 2019.PR NewswireGet Ready for the Summer With Astaxanthin From AlgatechFUJIFILM's research group conducted a 10-week randomized, double-blind, placebo-controlled clinical trial, published in June 2018 in the journal Nutrients, demonstrating that algal-derived astaxanthin from Algatechnologies Ltd. provides protective effects against UV-induced skin damage. The study found that participants taking 4mg of Haematococcus pluvialis microalgae-derived astaxanthin showed increased minimal erythema dose and reduced skin moisture loss compared to placebo. Algatechnologies Ltd. is promoting its AstaPure natural astaxanthin as an ideal summer supplement, positioning within a global nutricosmetics market estimated to reach $12.6 billion by 2024.PR NewswireAlgatech Partners With Sphera on MicroalgaeAlgatechnologies and Sphera Encapsulation have partnered to develop innovative microalgae-based functional ingredients, launching first with a water-soluble astaxanthin powder. This collaboration utilizes Sphera's proprietary encapsulation technology to enhance the bioavailability of Algatech's AstaPure product for the nutraceutical market.PR NewswireAlgatech Invests in Supreme HealthAlgatechnologies, an Israeli microalgae biotechnology company, has become the major shareholder in Supreme Health New Zealand Ltd., a natural astaxanthin producer, to expand distribution of algae-based products across the Asia-Pacific region. The partnership combines Algatech's cultivation technologies and AstaPure® brand with Supreme Health's unique Haematococcus pluvialis strain sourced from Nelson Lakes, New Zealand, and its established marketing channels in China, New Zealand, and Australia. The Asia-Pacific market for astaxanthin and algae-based products is valued at several hundred million dollars with rapid growth projected, and the collaboration aims to position Supreme Health as a major global player.PR NewswireAlgatech Offers Organic, Non-GMO Natural AstaxanthinAlgatech Ltd. announced that its 100% organic Haematococcus pluvialis microalgae powder and astaxanthin oleoresin have been granted non-GMO verification by the Non-GMO Project Inc., making Algatech the first and only astaxanthin manufacturer to achieve this verification. The certified products include Organic AstaPure® Astaxanthin and oleoresin, which are already USDA organic, GMP, kosher, and halal certified, with the microalgae cultivated in the Arava desert. This certification provides Algatech's partners in the supplement, food, and beverage industries with added value and verification of clean-label production standards.PR NewswireAstaPure® Astaxanthin Approved by Anvisa BrazilAlgatechnologies Ltd. (Algatech) received approval from Brazil's health regulatory agency (Anvisa) for its all-natural astaxanthin AstaPure® to be used as a food ingredient, making it the first astaxanthin supplier to market clean-label astaxanthin in Brazil. Brazil has the largest nutritional and supplements market in South America, with vitamins and dietary supplements recording $1.3 billion in sales in 2015. Algatech will collaborate with distributor Ayalla in São Paulo to promote and sell the product across food, cosmetics, and dietary supplements segments.